Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bourquin C et al. - Authors describe a novel strategy to target immunostimulatory oligonucleotides to the initiation site of the immune response while at the same time protecting from an indiscriminate and generalized activation of the immune system.


Previous Article Next Article

Today in Hematology/Oncology...keeping you current

Efficacy and safety of anti-tumour necrosis factor in elderly patients with rheumatoid arthritis: An observational study
Clinical Reviews in Allergy and Immunology, 06/25/09

The natural history of bladder carcinoma in situ after initial response to bacillus Calmette-Guerin immunotherapy
Urologic Oncology: Seminars and Original Investigations, 06/29/09

Anaphylaxis in patients with congenital bleeding disorders and inhibitors
Blood Coagulation & Fibrinolysis, 06/17/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address